MetaADEDB 2.0 @ LMMD
Niacinamide
(DFPAKSUCGFBDDF-UHFFFAOYSA-N)
Structure
SMILES
NC(=O)c1cccnc1
Type(s)
Approved; Investigational
ATC code(s)
A11HA01
Molecular Formula:
C6H6N2O
Molecular Weight:
122.125
Log P:
0.8808
Hydrogen Bond Acceptor:
3
Hydrogen Bond Donor:
1
TPSA:
55.98
CAS Number(s):
98-92-0
Synonym(s)
1.
Niacinamide
2.
Nicotinamide
3.
Vitamin B 3
4.
Vitamin PP
5.
3-Pyridinecarboxamide
6.
Enduramide
7.
Nicobion
8.
Nicotinsäureamid Jenapharm
9.
Papulex
10.
Vitamin B3
11.
3 Pyridinecarboxamide
12.
B 3, Vitamin
13.
B3, Vitamin
14.
Jenapharm, Nicotinsäureamid
External Link(s)
MeSHD009536
PubChem Compound936
BindingDB27507
ChEBI17154
CHEMBLCHEMBL1140
DrugBankDB02701
DrugCentral1906
KEGGcpd:C00153
dr:D00036
ZINC5878
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Accidental exposure to productFAERS: 1US FAERS
2Burning sensationFAERS: 1US FAERS
3NauseaFAERS: 1US FAERS
4PainFAERS: 1US FAERS
5PruritusFAERS: 1
Canada Vigilance: 2
Canada Vigilance
US FAERS
6Abdominal PainOFFSIDES
7Abdominal discomfortOFFSIDES
8AcidosisOFFSIDES
9Acute bronchitisOFFSIDES
10Alanine Aminotransferase IncreasedOFFSIDES
11Aldolase increasedOFFSIDES
12AnorexiaOFFSIDES
13Antinuclear antibody increasedOFFSIDES
14ApathyOFFSIDES
15AphoniaOFFSIDES
16AspergillosisOFFSIDES
17AstheniaOFFSIDES
18AtherosclerosisOFFSIDES
19BlepharospasmOFFSIDES
20Blood creatine phosphokinase increasedOFFSIDES
21Blood osmolarity decreasedOFFSIDES
22Blood sodiumOFFSIDES
23Brain Infarction19288225CTD
24Brain Ischemia19288225CTD
25Brain scan abnormalOFFSIDES
26Chemical and Drug Induced Liver Injury7590113
8742498
21630391
CTD
27Child Behavior Disorders150790CTD
28ChromaturiaOFFSIDES
29Cleft Palate4269736CTD
30ConfabulationOFFSIDES
31DemyelinationOFFSIDES
32DermatofibrosarcomaOFFSIDES
33DermatomyositisOFFSIDES
34Diabetes Mellitus, Experimental

View details

CTD
35Diabetic Cardiomyopathies23677724CTD
36DiarrheaOFFSIDES
37DyspepsiaOFFSIDES
38DysuriaOFFSIDES
39Erectile dysfunctionOFFSIDES
40Fatty LiverOFFSIDES
41FibromyalgiaOFFSIDES
42Flat affectOFFSIDES
43FlushingCanada Vigilance: 2Canada Vigilance
44Gastrointestinal perforationOFFSIDES
45Hepatitis COFFSIDES
46Hypercholesterolemia20696151CTD
47Hyperglycemia

View details

CTD
48Hyperlipoproteinemias20696151CTD
49Hypertriglyceridemia20696151CTD
50Hypoalphalipoproteinemias20696151CTD
51InfectionOFFSIDES
52Kidney Diseases21630391CTD
53Kidney FailureOFFSIDES
54Limb Deformities, Congenital4269736CTD
55Lung InjuryOFFSIDES
56Musculoskeletal stiffnessOFFSIDES
57Nerve Degeneration8298082CTD
58NoduleOFFSIDES
59Occult blood positiveOFFSIDES
60Ocular icterusOFFSIDES
61Patellofemoral Pain SyndromeOFFSIDES
62Pelvic venous thrombosisOFFSIDES
63Protein total decreasedOFFSIDES
64Pulmonary vascular disorderOFFSIDES
65Rectal polypOFFSIDES
66Rheumatoid NoduleOFFSIDES
67Rosacea18189062CTD
68Seizures2931304CTD
69Skin Neoplasms24792773CTD
70Skin irritationCanada Vigilance: 1Canada Vigilance
71Spinal column stenosisOFFSIDES
72SynovitisOFFSIDES
73TendinitisOFFSIDES
74ThrombophlebitisOFFSIDES
75Tinea VersicolorOFFSIDES
76Vascular insufficiencyOFFSIDES
77Vasculitis9131432CTD
78Ventricular Dysfunction, Left23677724CTD
79Walking aid userOFFSIDES
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120237

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.